Ganjapreneur.com

Connecticut Approves Autism, Female Orgasmic Difficulty as Medical Cannabis Qualifying Conditions

Woman patient having consultation with doctor (gynecologist or psychiatrist) and examining health in medical gynecological clinic or hospital mental health service center

Connecticut officials have approved two new conditions — autism spectrum disorder and female orgasmic difficulty/disorder — as qualifying conditions for the state medical cannabis program.

Full story continued below.

Advertisement

Advertise Here

The Connecticut Medical Cannabis Board of Physicians last week approved autism spectrum disorder and female orgasmic difficulty/disorder as qualifying conditions for the state medical cannabis program. 

There are now 42 qualifying conditions for adults and 11 for individuals under 18-years-old. The two conditions were approved by the board unanimously. 

An observational study published earlier this year in the journal Sex Medicine found 41% of 410 women “face challenges achieving orgasm.” Seventy-one percent of women included in the study found cannabis beneficial for helping them achieve orgasm. 

“Cannabis may be a treatment for women with difficulty achieving orgasm during partnered sex… Cannabis-related treatment appears to provide benefit to women who have female orgasm difficulties or dysfunction.” — Assessment of the effect of cannabis use before partnered sex on women with and without orgasm difficulty, 5/6/24, Sex Medicine 

According to NuggMD, 14 states – Colorado, Delaware, Georgia, Illinois, Iowa, Louisiana, Michigan, Minnesota, Missouri, New Mexico, Pennsylvania, Rhode Island, Texas, and Utah –and Puerto Rico had previously approved autism as a qualifying condition for medical cannabis access. 

In Connecticut, medical cannabis is not subject to sales and excise tax at dispensaries and hybrid retailers, medical cannabis patients receive priority entry at hybrid retailers, patients may purchase up to 5 ounces of medical cannabis per month, and patients can access certain products, including those with higher potency and some dosage forms. 

[mashshare]

Get daily news insights in your inbox. Subscribe

End


Exit mobile version